Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EVKG Ever-Glory International Group	$0.00	$0.00	$0.00 ▼ $0.01	$10K	3.84	14,004 shs	N/A
MGOL MGO Global	$0.31 -33.8%	$0.31	$0.10 ▼ $6.99	$894K	7.26	27.49 million shs	106.10 million shs
PMNT Perfect Moment	$0.31 +2.8%	$0.54	$0.22 ▼ $2.15	$9.73M	-3.74	441,868 shs	322,280 shs
SILO Silo Pharma	$0.60 +4.4%	$0.60	$0.41 ▼ $4.50	$2.69M	0.29	2.38 million shs	3.64 million shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EVKG Ever-Glory International Group	0.00%	0.00%	0.00%	0.00%	0.00%
MGOL MGO Global	0.00%	0.00%	0.00%	0.00%	-94.18%
PMNT Perfect Moment	-4.99%	+4.89%	-39.10%	-67.95%	-80.35%
SILO Silo Pharma	-3.41%	-6.17%	-2.16%	-44.20%	-46.29%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PMNT Perfect Moment	0.7989 of 5 stars	0.0	3.0	0.0	0.0	3.3	1.7	0.0
SILO Silo Pharma	1.1265 of 5 stars	0.0	4.0	0.0	0.0	2.2	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
EVKG Ever-Glory International Group	N/A	N/A	N/A
MGOL MGO Global	N/A	N/A	N/A
PMNT Perfect Moment	N/A	N/A	N/A
SILO Silo Pharma	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	$5.20M	0.17	N/A	N/A	$0.64 per share	0.48
PMNT Perfect Moment	$21.50M	0.45	N/A	N/A	$0.05 per share	6.26
SILO Silo Pharma	$70K	38.40	N/A	N/A	$1.12 per share	0.54

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EVKG Ever-Glory International Group	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	-$7.14M	-$4.57	N/A	∞	N/A	-142.93%	-412.85%	-291.72%	N/A
PMNT Perfect Moment	-$8.72M	-$0.99	N/A	∞	N/A	-67.38%	-513.83%	-119.38%	8/13/2025 (Estimated)
SILO Silo Pharma	-$4.39M	-$1.17	N/A	∞	N/A	-6,420.83%	-84.88%	-61.81%	8/12/2025 (Estimated)

Latest PMNT, SILO, MGOL, and EVKG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/9/2025	Q1 2025	SILO Silo Pharma	N/A	-$0.23	N/A	-$0.23	N/A	$0.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EVKG Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A
MGOL MGO Global	N/A	N/A	N/A	N/A	N/A
PMNT Perfect Moment	N/A	N/A	N/A	N/A	N/A
SILO Silo Pharma	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EVKG Ever-Glory International Group	N/A	N/A	N/A
MGOL MGO Global	N/A	14.13	8.37
PMNT Perfect Moment	N/A	1.01	0.70
SILO Silo Pharma	N/A	4.73	4.73

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EVKG Ever-Glory International Group	N/A
MGOL MGO Global	1.05%
PMNT Perfect Moment	23.00%
SILO Silo Pharma	5.58%

Insider Ownership

Company	Insider Ownership
EVKG Ever-Glory International Group	35.53%
MGOL MGO Global	12.60%
PMNT Perfect Moment	N/A
SILO Silo Pharma	4.37%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EVKG Ever-Glory International Group	4,300	14.66 million	N/A	Not Optionable
MGOL MGO Global	7	2.90 million	2.54 million	Not Optionable
PMNT Perfect Moment	31	31.08 million	N/A	N/A
SILO Silo Pharma	2	4.48 million	4.29 million	Not Optionable

PMNT, SILO, MGOL, and EVKG Headlines

Recent News About These Companies

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

July 16 at 8:45 AM | globenewswire.com

Silo Pharma (NASDAQ:SILO) Raised to "Sell" at Wall Street Zen

July 14 at 2:09 AM | americanbankingnews.com

Silo Pharma Secures Exclusive License for CNS Peptides

July 10, 2025 | tipranks.com

Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026 - Nasdaq

July 9, 2025 | nasdaq.com

Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026

July 7, 2025 | quiverquant.comQ

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

July 7, 2025 | globenewswire.com

Silo Pharma Faces Nasdaq Non-Compliance Notice

July 3, 2025 | msn.com

Silo Pharma and Hoth Therapeutics plan joint venture for obesity treatment

June 26, 2025 | investing.com

Silo Pharma and Hoth Therapeutics to Form Joint Venture for VA-Developed Obesity Treatment - Nasdaq

June 26, 2025 | nasdaq.com

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market - Morningstar

June 26, 2025 | morningstar.comM

Silo Pharma Enters LOI for Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 26, 2025 | jcnnewswire.comJ

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

June 25, 2025 | globenewswire.com

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

June 25, 2025 | prnewswire.com

Silo Pharma, Inc.: Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

June 11, 2025 | finanznachrichten.de

Silo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSD

June 11, 2025 | quiverquant.comQ

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

June 11, 2025 | globenewswire.com

16 Companies Announced A Bitcoin Treasury Last Week: Report

June 9, 2025 | coingape.comC

Silo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset

June 7, 2025 | nasdaq.com

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

June 5, 2025 | globenewswire.com

Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine

June 2, 2025 | newsfilecorp.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

PMNT, SILO, MGOL, and EVKG Company Descriptions

Ever-Glory International Group NASDAQ:EVKG

$0.0007 0.00 (0.00%)

As of 07/15/2025

Ever-Glory International Group, Inc., together with its subsidiaries, manufactures, supplies, and retails apparel in Mainland China, Hong Kong, Germany, the United Kingdom, Europe, Japan, and the United States. It operates through two segments, Wholesale and Retail. The company primarily offers casual wear, outerwear, and sportswear. Its products include coats, jackets, slacks, skirts, shirts, trousers, and jeans for women; vests, jackets, trousers, skiwear, shirts, coats, and jeans for men; and coats, vests, down jackets, trousers, knitwear, and jeans for children. The company offers its woman apparel under the La go go, Velwin, Sea To Sky, Jizhu, and idole brands. It also engages in the import and export of apparel, fabric, and accessories. The company provides its products directly to consumers through retail stores, as well as online stores at Tmall, Dangdang mall, JD.com, VIP.com, etc. As of March 31, 2022, it operated 848 stores in China. The company is based in Nanjing, the Peoples Republic of China.

MGO Global NASDAQ:MGOL

MGO Global, Inc. operates as a lifestyle brand portfolio company. The company is involved in the fashion design, brand development and management, sourcing and manufacturing, licensing, IP protection, corporate finance, consumer engagement and experience, ecommerce, and retail sales and marketing activities related to the Messi brand. MGO Global, Inc. was founded in 2018 and is headquartered in Fort Lauderdale, Florida.

Perfect Moment NASDAQ:PMNT

$0.31 +0.01 (+2.79%)

Closing price 04:00 PM Eastern

Extended Trading

$0.31 -0.01 (-1.60%)

As of 06:27 PM Eastern

Perfect Moment Ltd., together with its subsidiaries, owns and operates a fashion brand that offers ski, surf, and activewear collections under the brand name of Perfect Moment. It offers skiwear, outerwear, swimwear and activewear for women, men, and children. The company sells its collections directly to customers through e-commerce and to wholesale accounts, as well as through other sales partnerships. Perfect Moment Ltd. was founded in 1984 and is based in London, the United Kingdom.

Silo Pharma NASDAQ:SILO

$0.60 +0.03 (+4.40%)

Closing price 04:00 PM Eastern

Extended Trading

$0.62 +0.02 (+3.17%)

As of 06:26 PM Eastern

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time